A Pilot Clinical Trial to Assess Percutaneous Segmental Mastectomy in Women with Malignant Tumors < or = 1.0 Centimeter
Abstract
The operative treatment of primary breast cancer has changed. The radical mastectomy has been replaced by the modified radical mastectomy. Increasingly breast-conserving operations are being accepted as the standard of care. The logical culmination of the retreat from radical mastectomy is tumor extirpation without open surgical procedures. The biological rationale for this is the same rationale that resulted in the abandonment of en bloc tumor resection in favor of breast preservation. Recent& technology permits highly accurate tissue sampling of non-palpable mammographically imaged densities. An unanticipated observation associated with the use of stereotactic core biopsy was the complete removal of tumors up to 1.2 centimeters in diameter.
Document Details
- Document Type
- Technical Report
- Publication Date
- Sep 01, 1999
- Accession Number
- ADA383025
Entities
People
- Norman Wolmark